Browse and digest the latest news in neurosurgery

Message from NEUROSURGIC

Please observe that

we do not have the possibilty to

add more conferences

for the moment


Neurosurgical news

Keep yourself updated by browsing our news!

Select a news category from the menu to the right! For the latest news - login and go to the Startpage.

Neurosurgeon who beat the odds speaks at Erlanger

It took a marathon 19-hour surgery to remove the bulging tumor from the top of the child’s head, then meticulously piece the head back together.

But despite a “spectacularly” successful surgery, the baby died three weeks later, according to the neurosurgeon who performed the surgery, Dr. Ben Carson.

The child had languished in a nursing home “waiting to die” before Johns Hopkins doctors were made aware of the situation, and that delay had allowed the tumor to spread, Dr. Carson said Thursday during a lecture at Erlanger hospital.

Read more from Chattanooga Times Free Press

Deep brain stimulation approved for obsessive-compulsive disorder

People with severe obsessive-compulsive disorder have a new treatment option available: The Food and Drug Administration has approved deep brain stimulation as a therapy for the disorder.

With deep brain stimulation, electrodes permanently  implanted in a person’s brain emit electrical signals that alter the functioning of the brain’s complex circuitry.

Scientists aren’t yet sure how the intervention works. In some cases, it may activate brain circuits that are sluggish; in other cases, it may inhibit circuits that are overactive.

With OCD, it’s believed that hyperactive circuits contribute to heightened anxiety and, often, depression. People with the disorder indulge in repetitive behaviors, such as washing their hands incessantly or repeatedly making sure a door is shut, as a way of controlling anxiety.
Read more from Chicago Tribune

UT Southwestern Performs First Local Implant In Deep Brain Stimulation Study For Depression

UT Southwestern Medical Center neurological surgeons have begun implanting patients as part of a clinical study that is investigating whether deep brain stimulation (DBS) therapy may help people who suffer from major depressive disorder, a severe form of depression.

The BROADEN™ (BROdmann Area 25 DEep brain Neuromodulation) study is a controlled, multi-site, blinded, clinical study that is evaluating the safety and effectiveness of DBS therapy in patients with depression for whom currently available treatments are not effective. UT Southwestern is one of three U.S. sites currently participating in this clinical study.

Read full story from MediLexicon

Page 11 of 11

You are here: